Performance Food Group (PFGC)
NYSEConsumer StaplesFood DistributionSnapshot 2026-09-04
NYSEConsumer StaplesFood DistributionSnapshot 2026-09-04
Research Workspace
Put PFGC beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Staples is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 7% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMostly healthy — no soft spokes
PFGC's growth relies on achieving revenue targets of $72.5B-$73.0B for FY 2027. Recent sales growth of 6.4% supports this claim, despite a recent earnings miss. The stock trades at 22× P/E versus a peer median of 17×, indicating a premium valuation. This suggests the market expects strong growth, which may not be fully justified. A specific risk is the 24% probability of a miss in the next quarter, which could pressure the stock. Peer multiples imply a price about 10% above where it trades. Our read remains intact.
Trailing returns as of 2026-09-04. PFGC is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 14 analysts currently covering PFGC (as of Sep 2026).
Based on 5 Wall Street analysts offering 12-month price targets for PFGC in the last 4 months.
Continue this research
Compare PFGC with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| PFGC Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Food Distributors — fair value, gap to price, and forward P/E.
Compare the value case
Put PFGC next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase revenue to $72.5B-$73.0B for FY 2027
Initiatives directly support revenue growth objectives.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $98.63
The last 12 months of price, then the range of analyst 12-month targets from today’s $98.63.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Advances: Achieve Adjusted EBITDA of $2.125B-$2.225B for FY 2027
Record free cash flow supports EBITDA growth target.

Advances: Maintain gross profit growth through case volume and mix
Higher prices support gross profit growth objective.
Threatens: Increase revenue to $67.7B-$68.0B for FY 2026
Sales below estimates may hinder revenue growth.

Threatens: Achieve Adjusted EBITDA of $2.125B-$2.225B for FY 2027
Earnings miss could impact EBITDA growth expectations.
